Learn More
Medchemexpress LLC Pseudoprotodioscin | 102115-79-7 | 1031.18 | 5 MG

Supplier: Medchemexpress LLC HYN06865MG
Pseudoprotodioscin is a furostanoside that inhibits SREBP1/2 and microRNA 33a/b levels, leading to a reduction in the gene expression responsible for the synthesis of cholesterol and triglycerides. It is intended for research use only.
- Inhibits SREBP1/2 and microRNA 33a/b levels.
- Reduces gene expression related to cholesterol and triglyceride synthesis.
- Increases ABCA1 protein and mRNA levels.
- Promotes ApoA-1-mediated cholesterol efflux.
- Reduces HMGCR, FAS, and ACC mRNA levels.
- Promotes low-density lipoprotein receptor by decreasing PCSK9 levels.
- Purity: 99.17%.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.